A randomized crossover study between insulin glulisine and insulin aspart in patients with type 1 diabetes

A randomized crossover study between insulin glulisine and insulin aspart in patients with type 1 diabetes - A randomized crossover study between insulin glulisine and insulin aspart in patients with type 1 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021968

Enrollment

Registered

2016-04-18

Start date

2016-04-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

insulin glulisine injection for six days insulin aspart injection for six days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: # HbA1c above 5% under 9% # diabetes duration above 2 years # SAP (sensor augmented insulin pump) therapy # carb count method

Exclusion criteria

Exclusion criteria: # pregnant # oral steroid therapy # significant obesity # advanced diabetes coomplication

Design outcomes

Primary

Measure	Time frame
area under curve of blood glucose level between before meal and three hours after meal	—

Secondary

Measure	Time frame
peak level of blood glucose after meal, average and standard deviation of blood glucose level, frequency of hypoglycemia, impression from use	—

Countries

Japan

Contacts

Public ContactHotta Yuko

Osaka City University Pediatrics

kky_hotta@yahoo.co.jp06-6645-3816

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026